… recurrence, particularly among patients who have undergone surgery and irradiation. FDG
PET is particularly useful in breast cancer in the evaluation of patients with equivocal results …

… evaluation of a subjective, self-administered instrument designed to measure the needs of
patients with cancer. … of the multidimensional impact of cancer (including assessment of health …

… those patients had higher MDA levels than the patients with benign diseases (p = 0.009 and
p = 0.021, t-test). Our results showed also that plasma levels of MDA in cancer patients were …

… about rhe prevalence of pain in different cancer types, epidemiologic data on the prevalence
of … to evaluate the prevalence of 15 important symptoms and symptom groups in cancer of …

… For patients diagnosed in 2002, Medicare paid an average of $39 891 for initial … cancer
patient, $41 134 for each colorectal cancer patient, and $20 964 for each breast cancer patient, …

… some method of quantifying patients’ status relative to … patients with cancer, its reliability
and validity have generally been assumed without formal investigation. In this paper we evaluate …

… cancer pain, data on the prevalence of different pain syndromes are rare. In a prospective
study of 2266 cancer patients… Thirty percent of the patients presented with 1, 39% with 2 and 31…

… lymph node retrieval in colorectal cancer patients has not been examined on a broad
scale. We present a population-based analysis of lymph node evaluation in the United States. …

… Fatigue is a highly prevalent condition among cancer patients. Although most cancer patients
report that fatigue is a major obstacle to maintaining normal daily activities and quality of …

… In the current study, only results for the 428 cancer patients among the 437 consented
subjects are reported. Fifty-nine percent of the participating cancer patients were male, 90% were …